Intera to support the internationalisation and growth of Galena Pharma

Intera invests in pharmaceutical contract development and manufacturing company Galena Pharma. As a new co-owner, Intera will support Galena Pharma’s growth and internationalisation targets.

Galena Pharma is a leading Finnish contract manufacturer focused on developing and manufacturing pharmaceuticals, medical devices and nutritional supplements while offering other related support services. Galena Pharma mostly sells its products to companies that sell pharmaceuticals and healthcare products in Finland and other countries. The company’s revenue in 2020 was over 7 million euros and it employs around 40 people. www.galena.fi

Press release 7.1.2021

Related investment